In spite of the extensive potential of human mesenchymal stem cells (hMSCs) in cell therapy, little is known about the molecular mechanisms that regulate their therapeutic properties. We aimed to identify microRNAs (miRNAs) involved in controlling the transition between the resting and reparative phenotypes of hMSCs, hypothesizing that these miRNAs must be present in the undifferentiated cells and downregulated to allow initiation of distinct activation/differentiation programs. Differential miRNA expression analyses revealed that miR-335 is significantly downregulated upon hMSC differentiation. In addition, hMSCs derived from a variety of tissues express miR-335 at a higher level than human skin fibroblasts, and overexpression of miR-335 in hMSCs inhibited their proliferation and migration, as well as their osteogenic and adipogenic potential. Expression of miR-335 in hMSCs was upregulated by the canonical Wnt signaling pathway, a positive regulator of MSC self-renewal, and downregulated by interferon-c (IFN-c), a pro-inflammatory cytokine that has an important role in activating the immunomodulatory properties of hMSCs. Differential gene expression analyses, in combination with computational searches, defined a cluster of 62 putative target genes for miR-335 in hMSCs. Western blot and 3 0 UTR reporter assays confirmed RUNX2 as a direct target of miR-335 in hMSCs. These results strongly suggest that miR-335 downregulation is critical for the acquisition of reparative MSC phenotypes. . Upon activation by tissue damage, MSCs contribute to tissue-repair processes through a multitude of activities, including cell proliferation, differentiation and migration, and the regulation of angiogenesis and immune responses. There is growing evidence, in both animal and clinical models, that administration of ex vivo-expanded human MSCs (hMSCs) has potential to ameliorate many degenerative disorders; however, the specific molecular mechanisms underlying this therapeutic potential remain mostly unknown.
Mesenchymal stem cells (MSCs) are multipotent mesodermderived somatic stem cell (SSC) precursors of non-hematopoietic connective tissues that are present in the stroma of virtually all mammalian organs, especially bone marrow and subcutaneous fat (reviewed in Bernardo et al. 1 ). Upon activation by tissue damage, MSCs contribute to tissue-repair processes through a multitude of activities, including cell proliferation, differentiation and migration, and the regulation of angiogenesis and immune responses. There is growing evidence, in both animal and clinical models, that administration of ex vivo-expanded human MSCs (hMSCs) has potential to ameliorate many degenerative disorders; however, the specific molecular mechanisms underlying this therapeutic potential remain mostly unknown.
MicroRNAs (miRNAs) are an extensive family of small (18-24 nucleotide), single-stranded non-coding RNAs, which regulate gene expression in eukaryotic cells by controlling the translation (usually by repression), stability and localization of specific mRNA targets. Computational predictions of miRNA targets indicate that each miRNA regulates hundreds of mRNAs, and that approximately one third of all mammalian protein-coding genes are regulated by miRNAs. 2 Functional studies show that miRNAs participate in virtually each cellular process investigated, and that alterations in their expression levels might underlie human diseases, including cardiovascular disease and cancer. There are also data indicating that mammalian miRNAs can be imported into the nucleus 3 or even secreted from cells within small exocytic particles, 4 suggesting the existence of currently unknown functions for this class of molecules.
Experimental evidence shows that miRNAs are critical regulators of stem cell biology. In mouse embryonic stem (ES) cells, knockout of Dicer or DGCR8, two key protein factors involved in miRNA biogenesis, impairs cell growth, with cells accumulating in G1, and severely reduces differentiation capacity. 5, 6 Additionally, expression profiling demonstrates that ES cells express a unique repertoire of miRNAs compared with differentiated cell types. 7 Molecular functions of ES cell-specific miRNAs have begun to be elucidated, and the results confirm their critical involvement in the regulation of ES cell pluripotency and self-renewal. miRNAs also have an important role in controlling ES cell differentiation and commitment. 8 To date, relatively few studies have examined miRNA function in MSCs. Gene expression microarray profiling has identified several miRNAs that are regulated during differentiation of MSCs into different cell lineages. Some of these miRNAs have been identified as regulators of osteogenic differentiation, including miR-125b, 9 miR-26a, 10 miR-196a, 11 miR-204/211 12 and miRs-148b, -27a and -489. 13 Also, miR-335 has been recently identified as the most upregulated miRNA in bone marrow-derived hMSCs in comparison with skin fibroblasts, 14 which are otherwise phenotypically similar to hMSCs. However, the specific targets of most of these miRNAs remain to be determined, and the possible role of miRNAs in other therapeutically relevant MSC activities, such as in cell migration and proliferation, is unknown.
Here, we sought to identify miRNAs that may regulate the activation of the reparative phenotype of hMSCs, as well as some of their target genes.
Results miR-335 is downregulated upon hMSC differentiation. We hypothesized that key miRNA regulators of MSC activation/differentiation in tissue repair should be expressed in the undifferentiated state, and downregulated early upon exposure to a differentiation signal. To identify these putative miRNAs, we used Agilent microarrays to obtain differential miRNA expression profiles of undifferentiated bone marrow-derived hMSCs versus the same cells cultured in the presence of adipogenic or osteogenic media. We also profiled human skin fibroblasts, since the target miRNAs should be expressed at comparatively low levels in more developmentally restricted mesenchymal cell types. As we aimed to identify miRNAs potentially involved in the initial steps of hMSC activation/ differentiation, cells were exposed to differentiation media for a relatively short period (9 days), instead of the 21 days commonly used for in vitro MSC differentiation assays.
Signal processing is a critical step in the analysis of the results of miRNA microarray experiments. We used a normalization algorithm that incorporates quantile normalization between arrays 15 to estimate a processed miRNA signal for the Agilent arrays. The quantile normalization, when applied to the background-corrected signal, showed significantly lower variability between replicates than the total gene signal normalized by the 75% percentile (Supplementary Figure S1) .
The results showed no significant regulation (false discovery rate, fdro15%) of miRNAs previously described as regulators of osteogenic (miR-26a, miR-27a, miR-125b, miR-148b, miR-196a and miR-489) or adipogenic differentiation (miR-103, miR-107 and miR-143) under any of the conditions tested (Supplementary Figure S2A ; Supplementary Table S1 ). Gene enrichment analysis of the predicted targets of miRNAs up-or downregulated in at least two conditions (see Materials and methods) showed a significant (Po1E-06) enrichment for genes involved in angiogenesis or signaling by Wnt, integrins, PDGF, cadherin, endothelin and TGF-b (Supplementary Figure S2B; Supplementary Table S1) . miR-335 was the only miRNA significantly downregulated in all three 'differentiated' cell populations (Figure 1a) . Fold-change (log2) values were as follows: fibroblast versus Figure 1 miR-335 is downregulated in differentiated hMSCs and primary skin fibroblasts. (a) Total RNA was isolated from four bone marrow-derived MSC samples grown for 9 days in expansion medium or medium containing osteogenic or adipogenic supplements. In parallel, total RNA was also isolated from four dermal fibroblasts samples. The Venn diagrams show the number of miRNAs differentially expressed (fdro15%) in each differentiated cell population, analyzed on Agilent V2 miRNA arrays. For fibroblasts, samples (N ¼ 4) were analyzed individually, whereas for osteogenic and adipogenic differentiation, samples (N ¼ 4) were pooled (two pools, two independent samples each) before microarray analysis. (Figure 1b) , we selected miR-335 for further characterization.
miR-335 levels were also significantly reduced in human osteoblasts (Saos-2 cell line) after differentiation (Supplementary Figure S4 ).
hMSCs from different tissues express higher levels than fibroblasts of miR-335 and its host gene MEST. To determine whether relatively high expression of miR-335 is specific to bone marrow-derived hMSCs or is a common characteristic of hMSCs, we analyzed miR-335 expression levels in hMSC populations obtained from bone marrow, subcutaneous adipose tissue and articular cartilage ( Figure 2b) . All hMSC isolates were tested at passage 5-7 at the same cell density (8000 cells/cm 2 ), and were assayed for their differentiation potential to osteogenic, adipogenic and chondrogenic lineages in the presence of specific differentiation factors (data not shown). All three populations express significantly higher levels of miR-335 than dermal fibroblasts, and miR-335 expression levels were significantly higher in hMSCs isolated from bone marrow or articular cartilage than in hMSCs derived from adipose tissue.
miR-335 is encoded by the second intron of the MEST (mesoderm-specific transcript homolog) gene (Figure 2a) . 16 MEST expression, determined by real-time RT-PCR, correlated with the levels of mature miR-335 (Figure 2b ; Spearman's r ¼ 0.5769, P ¼ 0.0008), suggesting that the different hMSC isolates co-express mature miR-335 with its host gene and not through an MEST-independent mechanism (such as a specific promoter or post-transcriptional regulation).
MEST expression levels also correlated with the levels of miR-335 under all other conditions tested in this study (Supplementary Figure S5) . miR-335 impairs hMSC proliferation, migration and differentiation. We next analyzed the effect of miR-335 overexpression in bone marrow-derived hMSCs. hMSCs were transduced with the lentiviral vector pLV-EmGFP-MIR335, which encodes the genomic sequence spanning miR-335, or with a control vector (pLV-EmGFP-Mock). Transduced cells were purified to 495% homogeneity (gfppositive cells) by fluorescence-activated cell sorting (FACS). To avoid non-specific effects due to lentiviral gene silencing or to a high proviral copy number per cell, a multiplicity of infection (MOI) of 5 was used, and only cells with mediumlevel gfp expression were selected (Supplementary Figure  S3A) . Real-time RT-PCR demonstrated an B3-fold increase in miR-335 expression in pLV-EmGFP-MIR335-transduced cells compared with controls (Supplementary Figure S3B) .
When cultured over several passages, miR-335-overexpressing hMSCs showed a significant reduction in their proliferative activity compared with control cells (Figure 3a) . However, miR-335 overexpression did not cause significant alterations to cell cycle kinetics (not shown) or the rate of apoptosis (Figure 3b) .
hMSCs overexpressing miR-335 also showed an impaired migratory response to stimulation with fetal bovine serum (Figure 3c ). Consistently, wild-type hMSCs transfected with an miR-335 inhibitor (Anti-miR-335, Ambion, Austin, TX, USA) showed increased migratory activity compared with cells transfected with a negative control Anti-miR oligonucleotide (Figure 3c; Supplementary Figure S3C ). miR-335-overexpressing hMSCs also showed impaired migratory activity in an in vitro wound-healing assay compared with control cells (see Supplementary information videos). These results demonstrate that miR-335 is a negative regulator of hMSC migration.
The effect of miR-335 expression on hMSC differentiation capacity was monitored by comparing the in vitro differentiation responses of control and miR-335-transduced hMSCs to exposure to adipogenic or osteogenic stimuli for 3 weeks. Both adipogenic and osteogenic differentiation were significantly reduced by miR-335 overexpression. In particular, in vitro osteogenesis was almost completely abolished (Figure 3d Moreover, addition of Dkk1 (100 ng/ml), a specific inhibitor of canonical Wnt signaling, significantly decreased miR-335 expression in the presence of exogenous Wnt3a (Figure 4a , right panel). Upregulation of miR-335 expression by Wnt3a was also observed in adipose-derived hMSCs and in skin fibroblasts (Figure 4b ), although in a different extension, suggesting that this effect is common to all mesenchymal cell types.
We next evaluated the effect on miR-335 expression of interferon-g (IFN-g) signaling, another key regulator of MSC activity. IFN-g has numerous actions on MSC, including the induction of immunorregulatory activity, cell migration and osteogenic differentiation. 18, 19 Treatment of bone marrow-derived hMSCs with human IFN-g for 48 h significantly decreased expression of miR-335 ( Figure 4c ) in a dose-dependent manner, consistent with the lowered miR-335 expression during cell migration and osteogenic differentiation.
To identify possible binding sites in the MEST locus for transcription factors involved in b-catenin or IFNg signaling pathways, we performed a multispecies (human, mouse and dog) sequence homology analysis for conserved binding sites for LEF/TCF (transcription factors involved in b-catenin signaling) and STAT1 (involved in IFNg signaling). MULAN analysis with a matrix similarity of 0.95 showed one possible LEF1 and one possible TCF4 site in the 5-kb region upstream of the MEST transcriptional start site (corresponding to the longest human splicing variant), both mapping at À2675 kb (Supplementary Figure S6) . A similar analysis, with a matrix Potential miR-335 targets in hMSCs are enriched in transcription regulators of cell movement and differentiation. In order to identify potential miR-335 targets, we used a two-step approach (Figure 5a ). First, we employed three different miRNA target prediction programs, miRanda, 20 TargetScan 21 and PicTar, 22 to obtain a list of putative miR-335 targets. As these programs use different target scoring systems, we combined the three lists in a single non-redundant gene list (a total of 1838 genes, of which 1607 were mapped). Gene enrichment analysis using the PANTHER database revealed significant enrichment (Po0.001) for molecular functions related to transcriptional and post-transcriptional gene regulation, and for biological processes (Po1E-06) also related to regulatory activities, including mRNA transcription, protein modification and signal transduction (Supplementary Figure S7) .
Second, we performed a microarray gene expression analysis (Agilent Whole Human Genome Microarray Kit) on hMSCs transduced with pLV-EmGFP-MIR335 or pLVEmGFP-mock. We focused on downregulated genes since mRNA expression levels tend to correlate negatively with the expression levels of their specific miRNAs. 23 Using this approach, we identified 489 genes with decreased expression in miR-335-transduced cells that are thus candidate direct or indirect targets of this miRNA in hMSCs. Of these genes, 62 were also contained in the previously obtained list of predicted miR-335 targets (Supplementary Table S2 ), and were therefore classed as probable direct targets. This set of 62 genes was significantly enriched (Po0.05) for transcription factors (21%) and membrane-bound signaling molecules (6.5%). A detailed analysis with the Ingenuity Pathways Analysis software (IPA, Ingenuity Systems, Redwood City, CA, USA, http://www.ingenuity.com) showed a predominant enrichment for functions involved in cell development, cell movement, gene expression and the cell cycle (Benjamini-Hochberg multiple test-corrected P-value ¼ 1.37E 02-8.82E-02). Other significantly enriched biological functions included cell signaling, cell growth and proliferation, cell morphology, cell (Table 1) . Using IPA, the two more representative gene regulatory networks were constructed, respectively, containing 11 of the 20 potential miR-335 target genes involved in cellular movement (score 27) and 15 of the 17 genes involved in gene expression (score 42) (Figure 5b) . One of the predicted targets of miR-335 is RUNX2, a key transcription factor involved in osteogenesis. Although miRNAs can bind to coding regions and even to 5 0 regulatory regions, a single miR-335 binding site is predicted by the miRanda algorithm at nucleotides 3545-3567 in all the known RUNX2 transcript variants (GenGank Accession Numbers NM_001024630, NM_001015051, NM_004348), corresponding to the 3 0 UTR region. A western blot analysis of RUNX2 demonstrated that its protein levels are reduced in hMSCs by miR-335 exogenous overexpression (Figure 6a ). To determine whether miR-335 directly modulates RUNX2 expression levels in hMSCs, we cloned the full-length RUNX2 3 0 UTR downstream of the Renilla luciferase gene as a reporter, and assayed its expression in hMSCs transfected with a synthetic precursor or a specific inhibitor of miR-335. UTR reporters corresponding to SOX4 and UBE2F genes were used as positive and negative controls, respectively, for the miR-335 inhibitory activity. 24 Transfection of the miR-335 synthetic precursor significantly reduced the expression of UTR reporters for SOX4 and RUNX2, but not the expression of the negative control gene UBE2F (Figure 6b, upper panel) . Transfection with the specific inhibitor of miR-335 significantly increased the expression levels of UTR reporters for SOX4 and RUNX2, but did not affect the levels of UBE2F (Figure 6b , bottom panel). These results indicate that miR-335 controls RUNX2 expression in hMSCs by direct binding to its 3 0 UTR. Finally, we have quantified the relative expression levels of RUNX2 after osteogenic differentiation in hMSCs (Figure 6c) showed a significant reduction of RUNX2 expression levels in the cells transduced with the lentiviral vector encoding miR-335, compared with those transduced with a control lentiviral vector, which is in good agreement with the rest of the data indicating that RUNX2 is a target of miR-335 in hMSCs.
Discussion
Our results support a central role for miR-335 in the gene regulatory network that controls the tissue-repair activities of hMSCs. Expression of this miRNA is high in undifferentiated multipotent hMSCs compared with their differentiated cell progeny, and is regulated by major signaling pathways that control MSC biology, such as those controlled by Wnt3a and IFNg. The set of predicted miR-335 targets is enriched in genes whose products are regulators of cellular movement and gene expression, including RUNX2, involved in the control of osteogenic differentiation.
There is growing evidence that miRNAs have a critical role in the biology of all stem cell types, including ES cells, germline stem cells and SSCs. As SSCs are usually less well defined than embryonic or germline stem cells, it has been difficult to identify the specific roles of an miRNA in a particular SSC population. Most miRNAs described as regulators of SSC biology are inducers of cell differentiation/commitment or inhibitors of self-renewal and proliferation, while others seem to be involved in the self-renewal or maintenance of some SSC types. 25 Our results demonstrate that miR-335 is downregulated in hMSC cultures undergoing adipogenic or osteogenic differentiation, and is also expressed at comparatively lower levels in skin fibroblasts, which are mesenchymal cells with a limited differentiation potential. Our data are in complete accordance with previous work identifying miR-335 as the most upregulated miRNA in bone marrow-derived hMSCs in comparison with fibroblasts. 14 Until recently, the only known specific biological role for miR-335 is in human breast cancer, where it has been proposed as a metastasis suppressor. 24 Expression of miR-335 is lost in the majority of primary breast tumors from patients who relapse, and this is associated with poor distal metastasis-free survival. 24 These results are in good agreement with our findings demonstrating that miR-335 is a negative regulator of hMSC migration. miR-335 downregulation is also observed in drug-resistant ovarian cancer cells, 26 cultured chondrocytes (versus cartilage tissue), 27 ethanoltreated neural progenitors, 28 multiple myeloma cells and tumors 29 and muscle regeneration. 30 In contrast, miR-335 is highly expressed in obesity models 31 and in fetal lung compared with adult tissue. 32 During the preparation of this manuscript, a communication describing the direct targeting of RB1 by miR-335 has been published. 33 In this study, the authors establish the important role of this miRNA in the induction of p53-dependent cell cycle arrest after DNA damage. These results are in accordance with our findings demonstrating that miR-335 is a negative regulator of hMSC proliferation, and, taken together with our results, suggest an important role of miR-335/RB1 activity in regulation/activation of hMSC tissue-repair activities.
miR-335 is encoded by the second intron of the maternally imprinted gene MEST (human chromosome 7q32). 16 Our results demonstrate that both miR-335 and MEST are coordinately upregulated in hMSCs from three different tissues (bone marrow, subcutaneous fat and articular cartilage) in comparison with skin fibroblasts. The biological relevance of this finding remains to be determined, but our results suggest that miR-335 expression levels could be used to discriminate between hMSCs and fibroblasts, or even between different MSC populations with diverse differentiation potentials.
We found no significant regulation of miRNAs previously described as regulators of osteogenic differentiation (miR26a, miR-27a, miR-125b, miR-148b, miR-196a, miR-489 and miR-204/211) or adipogenic differentiation (miR-103, miR-107 and miR-143) under any of the conditions tested. This apparent discrepancy with published data might be related to the fact that our microarray analyses were performed on hMSCs at early differentiation stages, unlike other studies that used terminally differentiated MSCs. Also, the method we used for signal processing (quantile normalization) 15 probably contributed to an overall reduction in the variation of gene expression between samples.
The finding that miR-335 expression impairs the proliferative and migratory capacities of primary bone marrow-derived hMSCs and inhibits both adipogenic and osteogenic differentiation suggests that miR-335 is part of a common regulatory pathway for cell proliferation, migration and differentiation in MSCs. The existence of a partially overlapping regulatory circuitry for these biological processes has already been demonstrated in MSCs, 17 as well as in other SSC lineages. 34 The role of canonical Wnt signaling pathway (Wnt3a) as a positive regulator of miR-335 expression in hMSCs agrees with the evidence showing that Wnt3a inhibits osteogenic differentiation in MSCs. 17 However, the observed reduction in proliferation capacity in hMSCs overexpressing miR-335 suggests that the reported proliferative effect of Wnt3a acts via miR-335-independent mechanisms. Also, it has been reported that Wnt3a induces ECM invasion in hMSCs, 35 although it inhibits it in murine MSCs. 36 Further studies are needed to determine the effects of Wnt3a in the migration capacity of hMSCs in different regulatory conditions, and if they are related to miR-335 upregulation.
In contrast with the effect of Wnt3a, IFNg decreased miR-335 expression in hMSCs. Considered together with the anti-migratory and differentiation effects of miR-335, this action might account, at least partially, for the previously described pro-migratory and pro-osteogenic activities of IFNg. 19 This cytokine has a key role in the therapeutic activity of MSCs, as it is involved in the activation of their immunomodulatory phenotype. 18 IFNg signaling, both intercellular and autocrine, might thus regulate an unsuspected large number of genes in MSCs through the inhibition of miR-335 expression. At this time, we do not know the precise molecular mechanism by which IFNg downregulates miR-335 expression in MSC, but it might involve an indirect effect through its previously described inhibitory action on the canonical Wnt signaling pathway.
Comparative genomics is a powerful new tool for identifying and characterizing functional sequences. The presence in the 5 0 upstream region of the MEST locus of highly conserved potential LEF1 and TCF4-binding sites (95% similarity between human, mouse and dog) and potential STAT1-binding sites is compatible with the regulation of the MEST/ miR-335 locus by both Wnt3a and IFNg.
Consistent with our experimental results, the set of 62 potential direct gene targets of miR-335 is significantly enriched in genes related to cell movement and gene expression, pointing to a key regulatory role of miR-335 in MSC biology. In particular, we have experimentally validated RUNX2, a transcription factor essential for osteogenic differentiation, as a direct miR-335 target. Recently, miR-204 and miR-211 have been described as negative regulators of RUNX2. 12 Taken together, these results demonstrate that osteogenic differentiation of mesenchymal precursors is regulated by multiple miRNAs through the control of RUNX2 expression levels.
To our knowledge, this is the first demonstration of the involvement of a specific miRNA in the coordinated regulation of MSC proliferation, migration and differentiation. Our findings are summarized in the model presented in Figure 7 . miR-335 is downregulated in MSCs in response to tissue damage signals, such as IFNg, which leads to de-repression of miR-335 target genes involved in MSC proliferation, migration and osteogenic differentiation. These results have implications for the understanding of the major molecular mechanisms controlling the therapeutic activity of hMSCs versus their maintenance in an undifferentiated state, and strongly suggest an important role of miR-335 in tissue homeostasis.
Materials and Methods
Cell culture. This study was carried out according to the guidelines of the Instituto de Salud Carlos III (Spain). hMSCs from bone marrow, adipose tissue and articular cartilage were isolated and characterized as previously described. 38 Human skin fibroblasts were obtained from Inbiobank (San Sebastián, Spain). The 293T and the Saos-2 cell lines were purchased from The American Type Culture Collection (CRL-11268, Manasas, VA, USA). All cell lines were maintained in expansion medium, consisting of Dulbecco's modified Eagle's medium supplemented with 1 g/l D-glucose, supplemented with 10% heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine and 50 mg/ml gentamicin; all culture reagents were from Invitrogen (Carlsbad, CA, USA). Cells were cultured in a humidified 371C incubator at 5% CO 2 .
For Wnt stimulation, cells were exposed to different concentrations of conditioned medium from Wnt3a-expressing QT6 cells. Control and Wnt3a-expressing QT6 cells were kindly provided by Dr. D Büscher (Cellerix SL, Madrid, Spain).
When indicated, several factors (DKK1, R&D Systems, Minneapolis, MN, USA; IFNg, PeproTech, Rocky Hill, NJ, USA) or chemicals (KCl/LiCl, Sigma-Aldrich, St. Louis, MO, USA) were added to the hMSCs cells to evaluate its effect both on the modulation of miR-335 expression or on the several properties of the cells. In each case, the range of concentrations used is indicated.
Lentiviral vectors. The lentiviral vectors pLV-EmGFP-MIR335 (encoding the human miR-335 gene) and pLV-EmGFP-Mock (encoding a non-specific shRNA sequence) were based on pRRLsin18.PPT.CMV.GFP.Wpre, kindly provided by Dr. Luigi Naldini. 39 Detailed construction procedures for both plasmids are provided in Supplementary Information. Lentiviral particles were produced by transient transfection of 293T cells. 39 Lentiviral transduction was carried out by overnight incubation of 3 Â 10 5 hMSCs in 10 cm plates with 3 ml culture medium containing lentiviral particles at a MOI ¼ 5. Transduced (gfp þ ) cells were purified 48 h after transduction by FACS using a FACSAriaII SORP cell sorter (BD Biosciences, Franklin Lakes, NJ, USA).
Transfection of miRNA precursors and inhibitors. Anti-miR miRNA inhibitors (Ambion) are chemically modified, single-stranded nucleic acids designed to specifically bind and inhibit endogenous miRNAs. Pre-miR miRNA precursors (Ambion) are synthetic double-stranded oligoribonucleotides designed to match the sequence of specific miRNA:miRNA* duplexes. Depending on the experiment, AntimiR or Pre-miR oligos at a final concentration of 50 nM were transfected (Lipofectamine 2000, Invitrogen) into 2 Â 10 4 hMSCs cultured in 24-well plates (BD Biosciences) according to the oligonucleotide manufacturer's protocol.
Real-time RT-PCR. Total RNA was isolated from cultured cells with an miRNeasy Mini Kit (Qiagen, Valencia, CA, USA). Human miR-335, MEST, SPP1 (osteopontin), PPARG and RUNX2 transcripts were quantified by real-time RT-PCR using the corresponding TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA, USA). RNU48 and GAPDH were used as endogenous normalization controls for miRNAs and protein-coding genes, respectively.
Analysis of cell proliferation, cell cycle and apoptosis. Cell proliferation was assessed by seeding 6 Â 10 4 cells/2 ml/well in six-well plates (Corning, Lowell, MA, USA) and culturing for 30 days. The medium was replaced every 3-4 days, and the cells were harvested and counted once a week. Cumulative population doubling (CPD) was calculated as log 10 (number of cells harvested)-log 10 (number of cells seeded)/log 10.
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For cell cycle profiling, B1 Â 10 6 methanol:acetic acid-fixed cells were incubated with 10 mM propidium iodide and 10 mM RNase A for 1 h at 37 1C and analyzed by flow cytometry using a Becton-Dickinson LSR cytometer. Data were analyzed with the Summit v4.3 software (Dako Inc., Carpinteria, CA, USA).
For apoptosis analysis, cells were harvested and centrifuged at 2000 Â g for 5 min at room temperature, washed twice with PBS, and resuspended in 1 Â binding buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) at a concentration of 1 Â 10 6 cells/ml. A measure of 5 ml of Annexin V-DY634 Figure 7 Working model for miR-335 control of MSC activation. In healthy tissues (homeostasis), physiological levels of Wnt3a, in co-ordination with other stimuli, keep miR-335 expression levels high in MSCs. Upon tissue damage or challenge, IFNg, probably also in combination with other proinflammatory signals, induce miR-335 downregulation, which in turns causes the de-repression of its target genes, RUNX2 among them. This activates the MSC reparative phenotype, characterized by an increased proliferative, migratory and differentiation capacities miR-335 controls hMSC activation M Tomé et al (Immunostep, Salamanca, Spain) were added to 4 Â 10 5 cells suspended in 400 ml of binding buffer. As a negative control, 2 Â 10 5 cells were used without addition of Annexin V antibody. Cells were vortexed gently and incubated in the dark for 15 min at room temperature. Cells were centrifuged at 1000 Â g for 5 min, and 1 Â binding buffer (500 ml) and PI (5 ml) were added to each tube. The samples were analyzed by FACScan (BD Biosciences) using the Cell Quest software (BD Biosciences).
Cell differentiation assays. hMSCs were seeded at 2 Â 10 4 cells/cm 2 in expansion medium, and after 24 h, medium was replaced by the corresponding induction medium. Osteogenic medium contained expansion medium supplemented with 10 mM b-glycerophosphate, 0.1 mM dexamethasone and 0.2 mM ascorbic acid. Adipogenic medium contained expansion medium supplemented with 0.01 mM dexamethasone, 0.5 mM IBMX (3-isobutyl-1-methyl xanthine) and 60 mM indomethacin. In all cases, induction medium was replaced every 3-4 days and, on day 9 or 21 (depending on the experiment) cells were processed for histochemical analysis. Cells were fixed with 70% ethanol (1 h, 41C) and stained (5 min). For osteogenic assays, cells were stained with 40 mM Alizarin Red, pH 4.1. Cells cultured in adipogenic medium were stained with 2% Oil Red O. Analysis of the expression of marker genes for osteogenic (osteopontin) and adipogenic (PPARg) differentiation was performed by real-time RT-PCR as described above.
Cell migration assays. For transwell migration assays, hMSCs (1 Â 10 4 ) were cultured in medium containing 0.2% FCS in a 24-well tissue culture insert with an 8-mm pore size membrane (BD Biosciences). Fresh culture medium containing 10% FCS was added to the bottom well. After 6 h, the filter membranes were fixed with 70% ethanol and mounted in mounting medium containing DAPI. Migration of hMSCs was determined by counting the number of DAPI-stained nuclei on the underside of the membrane under Â 100 magnification, using CellProfiler image analysis software (http://www.cellprofiler.org).
For wound-healing assays, a 'wound' was created in a cell monolayer by scraping with a sterile plastic tip, and time-lapse video recordings were made by sequentially capturing microscopic images at 30 min intervals over a total period of 46 h. Western blot analysis. Whole-cell lysates for western blotting were extracted with lysis buffer containing 50 mM Tris (pH 8), 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100 and 0.25% sodium deoxycholate and protease inhibitor cocktail (Roche, Rotkreuz, Switzerland). Protein samples were resolved by 10% SDS-PAGE and gels transferred to nitrocellulose membranes (GE Healthcare, Little Chalfont, UK). Membranes were blocked with 5% non-fat milk for 1 h at room temperature and subsequently incubated overnight at 41C with primary antibodies at the following dilutions: RUNX2, 1 : 500 (Sigma-Aldrich) and b-actin, 1 : 5000 (AbCam, Cambridge, MA, USA). Signals were detected using the appropriate horseradish peroxidase-conjugated secondary antibody (Dako, Glostrup, Denmark). The blots were visualized by an enhanced chemiluminescence system (ECL; GE Healthcare) according to the manufacturer's instructions, and relative intensity of the specific bands were quantified by densitometry using the ImageJ software (http:// rsb.info.nih.gov/ij/).
UTR reporter assays. The full-length 3
0 UTRs of the putative miR-335 target gene RUNX2, as well as the negative control UBE2F and the positive control SOX4 genes were amplified from human genomic DNA (Novagen, Madison, WI, USA) and individually cloned into the Psicheck-2 dual luciferase reporter vector (Promega, Madison, WI, USA). hMSCs were then co-transfected with each reporter construct and with an miRNA synthetic precursor (Pre-miR-335 or Pre-miR negative control #2, Ambion) or antagonist (Anti-miR-335 or at Anti-miR negative control #1, Ambion) at a final concentration of 50 nM, as described above. Cells were lysed 30 h after transfection and the ratio of Renilla to firefly luciferase was measured with the dual luciferase assay (Promega). Normalized Renilla to firefly ratios were determined in the presence or absence of miR-335 inhibition.
Microarray analyses. The Agilent Human microRNA Microarray v2.0 (G4470B, Agilent Technologies) was used to identify miRNAs highly expressed in undifferentiated hMSCs. miRNA expression profiles of undifferentiated hMSCs were compared with profiles of human skin fibroblasts and of the same hMSC lines after 9 days of adipogenic or osteogenic induction.
The Agilent Whole Human Genome Microarray Kit (G4112F, Agilent Technologies, Santa Clara, CA, USA) was used to identify genes downregulated in hMSCs exogenously overexpressing miR-335. The mRNA expression profile of hMSCs transduced with lentiviral vector pLV-EmGFP-MIR335 was compared with that of hMSCs transduced with the control vector pLV-EmGFP-Mock.
A full description of the experimental procedures, data processing and statistical analysis used for both types of microarrays is included in Supplementary information. All microarrays have been submitted to the Gene Expression Omnibus database at http://www.ncbi.nlm.nih.gov/geo; accession number GSE19232.
Bioinformatic analysis. Computational miRNA target prediction analyses were carried out using the algorithms miRanda (http://www.microrna.org/microrna/ home.do), TargetScan (http://www.targetscan.org) and PicTar (http://pictar. mdc-berlin.de).
Human, mouse and dog MEST loci were aligned, and the extent of DNA sequence homology was computed with the web-based program MULAN (http:// mulan.dcode.org). 40 Using MULAN and multiTF (http://multitf.dcode.org) with the TRANSFAC professional V10.2 library database (http://www.biobase.de), binding sites for LEF1, TCF4 (0.95 matrix similarity) and STAT1 (0.9 matrix similarity) were predicted in the 5-kb upstream region of the human MEST locus.
Target gene functions were profiled with PANTHER software (http:// www.pantherdb.org/tools) and Ingenuity Pathways Analysis software (http:// www.ingenuity.com).
Statistical analysis. Statistical analyses of experimental data were conducted with Prism 3.0 (Graphpad Software Inc., San Diego, CA, USA). Unless otherwise stated, data were compared by the Mann-Whitney U-test for statistical significance. Results were considered statistically significant at Pr0.05.
